We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AG icon
2826
First Majestic Silver
AG
$9.07B
– –
-6,000
Closed -$57K
AGM icon
2827
Federal Agricultural Mortgage
AGM
$2.56B
– –
-66
Closed -$4K
AIN icon
2828
Albany International
AIN
$1.78B
– –
-17
Closed –
AIR icon
2829
AAR Corp
AIR
$5.76B
– –
-18
Closed –
AIV
2830
Aimco
AIV
$383M
$0 ﹤0.01%
84
+61
+265% +$271
AKBA icon
2831
Akebia Therapeutics
AKBA
$252M
– –
-413
Closed -$1K
ALB icon
2832
Albemarle
ALB
$15.5B
$0 ﹤0.01%
10
-8
-44% -$950
ALE
2833
DELISTED
Allete
ALE
$0 ﹤0.01%
+16
New +$907
AM icon
2834
Antero Midstream
AM
$10.1B
– –
-1,361
Closed -$7K
AMSF icon
2835
AMERISAFE
AMSF
$540M
$0 ﹤0.01%
+11
New +$636
BNBX
2836
DELISTED
BNB PLUS CORP
BNBX
– –
0
– -$38K
ARCT icon
2837
Arcturus Therapeutics
ARCT
$211M
$0 ﹤0.01%
+5
New +$339
AROC icon
2838
Archrock
AROC
$5.8B
– –
-184
Closed –
AVNW icon
2839
Aviat Networks
AVNW
$273M
– –
-5,000
Closed -$54K
AX icon
2840
Axos Financial
AX
$5.68B
– –
-452
Closed -$10K
BAK icon
2841
Braskem
BAK
$913M
$0 ﹤0.01%
+104
New +$884
BDN
2842
Brandywine Realty Trust
BDN
$554M
$0 ﹤0.01%
+80
New +$860
BFS
2843
Saul Centers
BFS
$841M
– –
-200
Closed -$5K
BNO icon
2844
United States Brent Oil Fund
BNO
$727M
$0 ﹤0.01%
50
– –
BNTC icon
2845
Benitec Biopharma
BNTC
$468M
$0 ﹤0.01%
18
– –
BPOP icon
2846
Popular Inc
BPOP
$11.1B
$0 ﹤0.01%
6
– –
BRKR icon
2847
Bruker
BRKR
$8.14B
– –
-30
Closed -$1K
BTO
2848
John Hancock Financial Opportunities Fund
BTO
$803M
– –
-1,400
Closed -$30K
CCD
2849
Calamos Dynamic Convertible & Income Fund
CCD
$742M
– –
-3,000
Closed -$68K
CENN icon
2850
Cenntro
CENN
$8.43M
– –
-3
Closed -$2K
112 113
114
115 116

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.